4i7c Citations

Structure-based design of covalent Siah inhibitors.

Abstract

The E3 ubiquitin ligase Siah regulates key cellular events that are central to cancer development and progression. A promising route to Siah inhibition is disrupting its interactions with adaptor proteins. However, typical of protein-protein interactions, traditional unbiased approaches to ligand discovery did not produce viable hits against this target, despite considerable effort and a multitude of approaches. Ultimately, a rational structure-based design strategy was successful for the identification of Siah inhibitors in which peptide binding drives specific covalent bond formation with the target. X-ray crystallography, mass spectrometry, and functional data demonstrate that these peptide mimetics are efficient covalent inhibitors of Siah and antagonize Siah-dependent regulation of Erk and Hif signaling in the cell. The proposed strategy may result useful as a general approach to the design of peptide-based inhibitors of other protein-protein interactions.

Articles - 4i7c mentioned but not cited (1)

  1. Two high-resolution structures of the human E3 ubiquitin ligase Siah1. Rimsa V, Eadsforth TC, Hunter WN. Acta Crystallogr Sect F Struct Biol Cryst Commun 69 1339-1343 (2013)


Reviews citing this publication (10)

  1. Tetrazoles via Multicomponent Reactions. Neochoritis CG, Zhao T, Dömling A. Chem Rev 119 1970-2042 (2019)
  2. New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeutics. He M, Zhou Z, Shah AA, Hong Y, Chen Q, Wan Y. Cell Div 11 4 (2016)
  3. Targeting the Hippo signalling pathway for cancer treatment. Nakatani K, Maehama T, Nishio M, Goto H, Kato W, Omori H, Miyachi Y, Togashi H, Shimono Y, Suzuki A. J Biochem 161 237-244 (2017)
  4. The inducible E3 ubiquitin ligases SIAH1 and SIAH2 perform critical roles in breast and prostate cancers. Knauer SK, Mahendrarajah N, Roos WP, Krämer OH. Cytokine Growth Factor Rev 26 405-413 (2015)
  5. Ubiquitin-Dependent Regulation of the Mammalian Hippo Pathway: Therapeutic Implications for Cancer. Nguyen TH, Kugler JM. Cancers (Basel) 10 E121 (2018)
  6. Regulation of the SIAH2-HIF-1 Axis by Protein Kinases and Its Implication in Cancer Therapy. Xu D, Li C. Front Cell Dev Biol 9 646687 (2021)
  7. Peptide-based covalent inhibitors of protein-protein interactions. Paulussen FM, Grossmann TN. J Pept Sci 29 e3457 (2023)
  8. E3 ubiquitin ligase-mediated regulation of vertebrate ocular development; new insights into the function of SIAH enzymes. Piedade WP, Famulski JK. Biochem Soc Trans 49 327-340 (2021)
  9. Advanced approaches of developing targeted covalent drugs. Gai C, Harnor SJ, Zhang S, Cano C, Zhuang C, Zhao Q. RSC Med Chem 13 1460-1475 (2022)
  10. Zooming into the structure-function of RING finger proteins for anti-cancer therapeutic applications. George M, Masamba P, Iwalokun BA, Kappo AP. Am J Cancer Res 13 2773-2789 (2023)

Articles citing this publication (19)